Inovio Pharmaceuticals
INO
#8897
Rank
โ‚ฌ0.12 B
Marketcap
1,78ย โ‚ฌ
Share price
2.48%
Change (1 day)
-54.95%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ8.6 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is โ‚ฌ8.6 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ11.4 M-58.28%
2023-12-31โ‚ฌ27.32 M-8.61%
2022-12-31โ‚ฌ29.9 M2.54%
2021-12-31โ‚ฌ29.15 M-8.15%
2020-12-31โ‚ฌ31.74 M-64.26%
2019-12-31โ‚ฌ88.82 M
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31โ‚ฌ8.45 M-2.38%
2008-12-31โ‚ฌ8.66 M
2003-12-31โ‚ฌ0.26 M1232.07%
2002-12-31โ‚ฌ0.01 M-63.76%
2001-12-31โ‚ฌ0.05 M
2001-03-31โ‚ฌ0.13 M8.41%
2000-03-31โ‚ฌ0.12 M33.61%
1999-03-31โ‚ฌ0.09 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚ฌ52.26 B 607,153.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 456,926.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ0.30 B 3,423.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ27.50 B 319,474.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚ฌ35.53 B 412,805.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ20.49 B 238,038.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
โ‚ฌ21.42 B 248,807.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA